Cargando…

The relationship between liver histology and thyroid function tests in patients with non-alcoholic fatty liver disease (NAFLD)

BACKGROUND: Data on the role of hypothyroidism in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis are conflicting, although selective Thyroid Hormone Receptor (THR)-β agonists have been identified as potential therapy in patients with non-alcoholic steatohepatitis (N...

Descripción completa

Detalles Bibliográficos
Autores principales:	D'Ambrosio, Roberta, Campi, Irene, Maggioni, Marco, Perbellini, Riccardo, Giammona, Enza, Stucchi, Roberta, Borghi, Marta, Degasperi, Elisabetta, De Silvestri, Annalisa, Persani, Luca, Fugazzola, Laura, Lampertico, Pietro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023543/ https://www.ncbi.nlm.nih.gov/pubmed/33822817 http://dx.doi.org/10.1371/journal.pone.0249614

Ejemplares similares

Predicting Hepatocellular Carcinoma Risk in Patients with Chronic HCV Infection and a Sustained Virological Response to Direct-Acting Antivirals
por: D’Ambrosio, Roberta, et al.
Publicado: (2021)

Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19”
por: Iavarone, Massimo, et al.
Publicado: (2020)

Spike-specific humoral and cellular immune responses after COVID-19 mRNA vaccination in patients with cirrhosis: A prospective single center study
por: Iavarone, Massimo, et al.
Publicado: (2023)

Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon
por: D’Ambrosio, Roberta, et al.
Publicado: (2016)

Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies
por: Degasperi, Elisabetta, et al.
Publicado: (2022)

Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022
por: Lampertico, Pietro, et al.
Publicado: (2023)

Humoral, cellular, clinical responses and safety to SARS-CoV-2 messanger RNA vaccines in patients with compensated and decompensated cirrhosis: a long-term single center prospective study
por: Iavarone, Massimo, et al.
Publicado: (2022)

Liver fibrosis and CD206(+) macrophage accumulation are suppressed by anti-GM-CSF therapy
por: Tan-Garcia, Alfonso, et al.
Publicado: (2019)

The Association of Il28b Genotype with the Histological Features of Chronic Hepatitis C Is HCV Genotype Dependent
por: D’Ambrosio, Roberta, et al.
Publicado: (2014)

Association between metabolic syndrome and liver histology among NAFLD patients without diabetes
por: Kanwar, Pushpjeet, et al.
Publicado: (2016)

Limited Utility of ITPA Deficiency to Predict Early Anemia in HCV Patients with Advanced Fibrosis Receiving Telaprevir
por: Aghemo, Alessio, et al.
Publicado: (2014)

Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma
por: Scagliola, Alessandra, et al.
Publicado: (2021)

Telomeres, NAFLD and Chronic Liver Disease
por: Donati, Benedetta, et al.
Publicado: (2016)

Inflammation: The Straw That Broke the NAFLD Liver!
por: Raeman, Reben
Publicado: (2022)

Treatment of Non-Alcoholic Steatosis: Preclinical Study of a New Nutraceutical Multitarget Formulation
por: Micheli, Laura, et al.
Publicado: (2020)

Correlation between HDL2, HDL3 and serum ferritin levels with fatty liver and NAFLD activity score (NAS) in liver histology of organ donors
por: Nikeghbalian, Saman, et al.
Publicado: (2021)

Rebuttal to: Inflammation: The Straw That Broke the NAFLD Liver!
por: Mooli, Raja Gopal Reddy, et al.
Publicado: (2022)

Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker
por: Baselli, Guido Alessandro, et al.
Publicado: (2020)

The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
por: Song, Qian, et al.
Publicado: (2022)

High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study
por: Duseja, Ajay, et al.
Publicado: (2019)

The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD)
por: Carulli, Lucia, et al.
Publicado: (2019)

Effect of Aerobic Exercise on Liver Tissue in Rats with NAFLD
por: Li, Li, et al.
Publicado: (2022)

Cellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLD
por: Sanchez, Jessica I., et al.
Publicado: (2023)

Presence of cadmium residues in muscle, liver and kidney of Bubalus bubalis and histological evidence
por: Barrasso, Roberta, et al.
Publicado: (2018)

The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in Children
por: de Oliveira, Felipe Leite, et al.
Publicado: (2019)

Implementation of HCV screening in the 1969–1989 birth-cohort undergoing COVID-19 vaccination: a pivotal study in Italy
por: D’Ambrosio, Roberta, et al.
Publicado: (2022)

Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD
por: Wang, Junling, et al.
Publicado: (2016)

Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)
por: Polyzos, Stergios A., et al.
Publicado: (2020)

Eicosanoids in Nonalcoholic Fatty Liver Disease (NAFLD) Progression. Do Serum Eicosanoids Profile Correspond with Liver Eicosanoids Content during NAFLD Development and Progression?
por: Maciejewska, Dominika, et al.
Publicado: (2020)

Plasma Levels of Homocysteine and Cysteine Increased in Pediatric NAFLD and Strongly Correlated with Severity of Liver Damage
por: Pastore, Anna, et al.
Publicado: (2014)

Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features
por: Vonghia, Luisa, et al.
Publicado: (2015)

Fetal cell microchimerism and susceptibility to COVID-19 disease in women
por: Cirello, Valentina, et al.
Publicado: (2023)

Correction: Fetal cell microchimerism and susceptibility to COVID-19 disease in women
por: Cirello, Valentina, et al.
Publicado: (2023)

Impact of Health Related QoL and Mediterranean Diet on Liver Fibrosis in Patients with NAFLD
por: Perez-Diaz-del-Campo, Nuria, et al.
Publicado: (2023)

COVID-19 Vaccine Acceptance among Liver Transplant Recipients
por: Costantino, Andrea, et al.
Publicado: (2021)

Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
por: Del Campo, José A, et al.
Publicado: (2018)

The Crosstalk between Fat Homeostasis and Liver Regional Immunity in NAFLD
por: Ma, Minjuan, et al.
Publicado: (2019)

Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
por: Tomasiewicz, Krzysztof, et al.
Publicado: (2018)

CHD is Associated With Higher Grades of NAFLD Predicted by Liver Stiffness
por: Song, Yan, et al.
Publicado: (2020)

Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Zarghamravanbakhsh, Paria, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_il8thhjggjnid2p0v6vrv2k89r